55 results
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
24 Apr 24
Other Events
4:20pm
, by telephone at 1-866-803-9204, or by email at prospectus-eq_fi@jpmchase.com; Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th … , 28255-0001, Attn: Prospectus Department, Email: dg.prospectus_requests@bofa.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick
8-K
EX-1.1
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
Revenue Service, the U.S. Department of Labor, the Pension Benefit Guaranty Corporation or any other governmental agency or any foreign regulatory … administered or enforced by the U.S. government, (including, without limitation, the Office of Foreign Assets Control of the U.S. Department
8-K
EX-99.2
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
at 1-866-803-9204, or by email at prospectus-eq_fi@jpmchase.com; Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor … , Attn: Prospectus Department, Email: dg.prospectus_requests@bofa.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street
8-K
EX-99.1
ITCI
Intra-Cellular Therapies Inc
16 Apr 24
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
4:40pm
at prospectus-eq_fi@jpmchase.com; Leerink Partners LLC, Attention: Syndicate Department, 53 State Street, 40th Floor, Boston, MA 02109, (800) 808-7525 ext … . 6105, syndicate@leerink.com; BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC, 28255-0001, Attn: Prospectus Department
8-K
EX-10.1
9w879b0 i82xzqwya0e
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
8-K
EX-99.1
mwb2sq0d468uuba4v9i
7 Jan 22
Other Events
4:12pm
8-K
EX-99.2
7sh50dxbuyt 5ds14i
5 Jan 22
Entry into a Material Definitive Agreement
5:06pm
8-K
EX-1.1
e9mu vuca
5 Jan 22
Entry into a Material Definitive Agreement
5:06pm
8-K
EX-10.1
axolob0n
5 Jan 22
Financial Statements and Exhibits
4:58pm
8-K
EX-99.1
v0vsmkz5bo626tcx
4 Jan 22
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
12:00am
PRE 14A
0t7yjl5hjnm
19 Apr 21
Preliminary proxy
5:28pm
8-K
EX-99.2
7xswih
11 Sep 20
Entry into a Material Definitive Agreement
4:47pm
8-K
EX-1.1
29g suidbb2x8
11 Sep 20
Entry into a Material Definitive Agreement
4:47pm
8-K
EX-99.1
15pj8
9 Sep 20
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
5:26pm